Market Fit Bio-Me specializes in microbiome analysis with PMP technology, a fit for healthcare institutions, pharma, and consumer care companies seeking routine, rapid, and cost-competitive microbiome profiling services across gut, skin, and vaginal ecosystems.

Small Team Advantage With a lean team (11-50 employees) and revenue under one million, target partnerships can emphasize scalable outsourcing, quick onboarding, and flexible engagement models that leverage Bio-Me’s proprietary assay database without requiring large customer-side investments.

Global Partnerships Oslo-based Bio-Me already partners with leading healthcare institutions and multinational companies; outbound efforts should prioritize establishing collaborations with hospitals, CROs, and pharma players seeking standardized and validated microbiome assays.

Proprietary Edge Leverage Bio-Me’s PMP™ platform and custom assay development capability as differentiators for customers needing tailored microbiome tests, enabling upsell from routine profiling to bespoke assay development and validation services.

Growth Triggers Market trends toward precision microbiome profiling and personalized health create demand for cost-efficient, scalable analytics; position Bio-Me as a high-value, out‑sourced provider for routine testing, assay design, and analytics at a reduced total cost of ownership.